Although not a high priority for Neuren right now, it will be interesting to see what indication/s Neuren will be looking to pursue for NNZ-2591. An indication that may give Neuren a quick signal might be Peripheral Neuropathy induced by chemotherapy. Very very big market. NNZ-2591
We have allocated some resources to develop a reliable manufacturing process for NNZ-2591 and, as we did with NNZ-2566, to conduct a study with the US Army to elucidate the mechanism of action. These initial steps will inform our future decisions about which indications to pursue and how to position the molecule with respect to commercialisation.
NEU Price at posting:
2.3¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)